ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.110
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
1.090
-0.020 (-1.80%)
After-hours: Jun 27, 2025, 7:56 PM EDT
ImmunoPrecise Antibodies Employees
As of April 30, 2024, ImmunoPrecise Antibodies had 101 total employees, including 72 full-time and 29 part-time employees. The number of employees decreased by 1 or -0.98% compared to the previous year.
Employees
101
Change (1Y)
-1
Growth (1Y)
-0.98%
Revenue / Employee
$164,169
Profits / Employee
-$319,781
Market Cap
50.80M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 101 | -1 | -0.98% |
| Apr 30, 2023 | 102 | 17 | 20.00% |
| Apr 30, 2022 | 85 | 12 | 16.44% |
| Apr 30, 2021 | 73 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IPA News
- 4 days ago - ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology - Business Wire
- 16 days ago - AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies - Business Wire
- 23 days ago - ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery - Business Wire
- 5 weeks ago - ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts - Business Wire
- 5 weeks ago - ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference - Business Wire
- 6 weeks ago - IPA's LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed - Business Wire
- 2 months ago - ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - Business Wire
- 3 months ago - ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript - Seeking Alpha